Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ayurcann Holdings Corp C.AYUR

Alternate Symbol(s):  AYURF

Ayurcann Holdings Corp. is a Canada-based cannabis extraction company. The Company is specialized in the processing and manufacturing of pharma grade cannabis and hemp for various derivative cannabis products. The Company, through its wholly owned subsidiary, Ayurcann Inc, is a licensed producer focused on providing cannabis products in verity of categories for the recreational and medical use in Canadian Market. The Company’s brands include Fuego, H&S, Xplor, and JOINTS. Fuego offers various products, including Vapes, Infused, Sunny Daze, and Night Rider. Xplor offers various products, including Vapes, and Infused.


CSE:AYUR - Post by User

Comment by mahoonon Oct 29, 2021 7:51pm
135 Views
Post# 34066622

RE:Completes Phase 2 Build-Out and Distributes Earn-Out Payment

RE:Completes Phase 2 Build-Out and Distributes Earn-Out PaymentI was disappointed with the markets reaction to the latest NR.  We're " PROFITABLE ! "  , Certainly not all the Canadian Cannabis companies can claim that.  I guess too many people got burned in the enormous run up of MJ stocks a couple of years ago. Well I can wait a few more quarters to get a better idea how this is going to play out . GLTA

-  
  • Ayurcann reported record revenues of $7,633,656 for the fiscal year ending June 30, 2021, an increase of 1,149% over fiscal year 2020·     

-

  • Ayurcann reported substantial growth in Operating Income of $2,159,309, an increase of 440% over fiscal year 2020 and representing gross margins of approximately 60%.

 

<< Previous
Bullboard Posts
Next >>